Short Interest in Bonk, Inc. (NASDAQ:BNKK) Decreases By 48.9%

Bonk, Inc. (NASDAQ:BNKK) saw a large decline in short interest during the month of May. As of May 29th, there was short interest totaling 426,285 shares, a decline of 48.9% from the May 14th total of 834,243 shares. Approximately 11.0% of the shares of the company are short sold. Based on an average daily volume of 547,519 shares, the short-interest ratio is presently 0.8 days.

Bonk Price Performance

BNKK stock opened at $1.35 on Friday. The firm’s fifty day simple moving average is $2.26 and its 200-day simple moving average is $3.26. The company has a market capitalization of $10.80 million, a P/E ratio of -0.29 and a beta of 1.85. Bonk has a 12 month low of $1.25 and a 12 month high of $46.90.

Bonk (NASDAQ:BNKK) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.23) EPS for the quarter. The business had revenue of $0.79 million during the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%.

Analyst Upgrades and Downgrades

Several analysts have recently commented on BNKK shares. Weiss Ratings downgraded shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, April 29th. Wall Street Zen raised shares of Bonk from a “sell” rating to a “hold” rating in a report on Saturday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Bonk has an average rating of “Sell”.

Insiders Place Their Bets

In related news, Director Mitchell Austin Rudy bought 31,055 shares of the company’s stock in a transaction on Thursday, April 9th. The shares were bought at an average price of $2.82 per share, with a total value of $87,575.10. Following the transaction, the director owned 44,198 shares in the company, valued at approximately $124,638.36. This trade represents a 236.29% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 51.60% of the company’s stock.

Hedge Funds Weigh In On Bonk

Several large investors have recently made changes to their positions in the company. State Street Corp acquired a new position in shares of Bonk in the 4th quarter valued at $33,000. Steward Partners Investment Advisory LLC acquired a new position in shares of Bonk in the 4th quarter valued at $37,000. Jane Street Group LLC acquired a new position in shares of Bonk in the 4th quarter valued at $96,000. Finally, Geode Capital Management LLC acquired a new position in shares of Bonk in the 4th quarter valued at $128,000. 12.55% of the stock is currently owned by institutional investors and hedge funds.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.